Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyApar Kishor Ganti, Miranda Hughes, Anne C. Chiang et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 459
Analysis of first-line treatment (tx) patterns in advanced non-small cell lung cancer (NSCLC) patients (pts) with compromised performance status (PS), organ dysfunction (dfxn) or other significant comorbidities.Julia Judd, Martin J. Edelman, Elizabeth A. Handorf et al.|Journal of Clinical Oncology|2021Cited by 0